Attachment Inhibitor Comparison in Heavily Treatment Experienced Patients Read more about Attachment Inhibitor Comparison in Heavily Treatment Experienced Patients
Perceval S Aortic Heart Valve Study- North America Read more about Perceval S Aortic Heart Valve Study- North America
A Multicenter Study of the Efficacy and Safety of Xyrem With an Open- Label Pharmacokinetic Evaluation and Safety Extension in Pediatric Subjects With Narcolepsy With Cataplexy Read more about A Multicenter Study of the Efficacy and Safety of Xyrem With an Open- Label Pharmacokinetic Evaluation and Safety Extension in Pediatric Subjects With Narcolepsy With Cataplexy
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies Read more about Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Investigational Device Exemption Study to Determine the Safety and Efficacy of the Astron and Pulsar Stents Read more about Investigational Device Exemption Study to Determine the Safety and Efficacy of the Astron and Pulsar Stents
Efficacy and Safety of Intravenous Neridronic Acid in CRPS-I Read more about Efficacy and Safety of Intravenous Neridronic Acid in CRPS-I
Study to Evaluate the Safety and Efficacy of USL261 (Intranasal Midazolam) in Patients With Seizure Clusters Read more about Study to Evaluate the Safety and Efficacy of USL261 (Intranasal Midazolam) in Patients With Seizure Clusters
"A Long-Term Safety Study of JZP-110 in the Treatment of Excessive Sleepiness in Subjects With Narcolepsy or OSA" Read more about "A Long-Term Safety Study of JZP-110 in the Treatment of Excessive Sleepiness in Subjects With Narcolepsy or OSA"
Intracardiac CrYoablation for AtrioVentricular Nodal Reentrant Tachycardia Read more about Intracardiac CrYoablation for AtrioVentricular Nodal Reentrant Tachycardia
Open-label Safety Study of E/C/F/TAF (Genvoya®) in HIV-1 Positive Patients With Mild to Moderate Renal Impairment Read more about Open-label Safety Study of E/C/F/TAF (Genvoya®) in HIV-1 Positive Patients With Mild to Moderate Renal Impairment